semaglutide and intestinal obstruction Ozempic Bowel Blockages semaglutide bowel issues Comparative safety

As rates of metabolic dysfunction-associated steatohepatitis (MASH) rise among people with type 2 diabetes, many clinicians are rethinking how they prioritize treatment

Lancet 2:632, 1977 Thompson J, Greeley GH Jr, Rayford PL, Twonsed CM Jr: Gastrointestinal Endocrinology

This approach, similar to the convenience of wearable devices and DNA testing, makes GLP-1 therapy a staple in the metabolic health toolkit

The ratio of the fluorescence emission intensity upon excitation at 405 nm and 488 nm reflects changes in the dithiol disulfide state of the probe and, in combination with fully oxidized and reduced controls, allows the determination of the degree of the probe oxidation independent of probe concentration (Degrossoli et al., 2018

NICE provides clear criteria for bariatric surgery referral, including lower BMI thresholds for people of Asian family origin and expedited pathways for those with recent-onset type 2 diabetes

Judah Folkman leaves expanding legacy